Indication
Multiple Myeloma at First Relapse
1 clinical trial
3 products
Clinical trial
A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse."Status: Active (not recruiting), Estimated PCD: 2025-01-01
Product
IxazomibProduct
IberdomideProduct
Dexamethasone